Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 2330.TW
Valuation Weak
28%
Profitability n.A.
Fin. Growth Bad
0%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -0.47 2.39 2.40
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -36.89 -1.69 -1.23
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 5.12 140.21 133.38
Cash 13.93 74.15 65.08
Capex -46.98 -7.07 -4.81
Free Cash Flow -4.43 10.30 10.78
Revenue -5.25 22.86 24.12
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 0.06 0.53 0.53
Operating Margin 1.09 0.42 0.42
ROA -14.46 0.04 0.05
ROE -14.86 0.06 0.07
ROIC -10.14 0.05 0.05
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 2330.TW is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 2330.TW is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 2330.TW is permitted for members.